Start Date
October 31, 2010
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
Aralast NP
Participants will receive IV infusions of Aralast NP (90mg/kg) once a week for 12 weeks.
Placebo
Participants will receive IV infusions of placebo once a week for 12 weeks.
Columbia University, New York
The Children's Hospital of Philadelphia, Philadephia
Calvert Memorial Hospital, Prince Frederick
University of Maryland Medical Center, Baltimore
Atlanta Diabetes Associates, Atlanta
Emory University, Atlanta
Nationwide Children's Hospital, Columbus
University of Iowa, Iowa City
Cetero Research San Antonio, San Antonio
Barbara Davis Center, Aurora
University of California San Diego, La Jolla
Yale University, New Haven
Massachusetts General Hospital, Boston
Joslin Diabetes Center, Boston
University of Massachusetts Medical School, Worchester
Collaborators (1)
Immune Tolerance Network (ITN)
NETWORK
Juvenile Diabetes Research Foundation
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH